Preeclampsia: a report and recommendations of the workshop of the Society for Maternal-Fetal Medicine and the Preeclampsia Foundation

Preeclampsia is a substantial cause of perinatal and maternal morbidity and mortality. The prevalence of this condition has increased over the past several decades. Additional opportunities are needed to foster interdisciplinary collaborations and improve patient care in the setting of preeclampsia. In recognition of the Preeclampsia Foundation's 20th anniversary and its work to advance preeclampsia research and clinical agendas, a 2-day virtual workshop on preeclampsia was cosponsored by the Society for Maternal-Fetal Medicine and the Preeclampsia Foundation and held January 25-26, 2021 in conjunction with the 41st annual pregnancymeeting. Leaders with expertise in preeclampsia research, obstetrical care, primary care medicine, cardiology, endocrinology, global health, and patient advocacy gathered to discuss preeclampsiaprediction, prevention, management, and long-termimpacts. The goals of theworkshopwere to review the following issues and create consensus concerning research and clinical recommendations: center dot To present innovative opportunities for research on predicting, preventing, and managing preeclampsia center dot To review the benefits and challenges associated with various strategies for preeclampsia prediction, prevention, management, and postpartum follow-up center dot To identify research gaps for the prediction, prevention, management, and postpartum follow-up of preeclampsia center dot To discuss needs and opportunities for research, increasing awareness, and risk mitigation of the long-term effects of preeclampsia This report, developed collaboratively between the SMFM and the Preeclampsia Foundation, presents the key findings and consensus-based recommendations from the workshop participants.